Skip to main content

Anti-platelets in diabetes management

Buy Article:

$43.00 plus tax (Refund Policy)


This study aimed to determine the prevalence of anti-platelet use, and the extent to which contraindications to anti-platelet therapy prevent its use, in 726 diabetic patients attending a private clinic. Among those who reported a history of cardiovascular disease (CVD), 87.1% were on anti-platelet therapy. Of those without prior CVD but with at least one CVD risk factor, 59.8% were not on anti-platelet therapy, but only 7.1% of these had a contraindication to anti-platelet therapy. This study showed that high usage of anti-platelet therapy in diabetic patients with prior CVD is achievable, and that contraindications did not explain low use in those without prior CVD.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: aspirin; cardiovascular disease; complications; diabetes mellitus; prevention and control; type 2

Document Type: Research Article

Affiliations: 1: Baker IDI Heart and Diabetes Institute, and 2: Murdoch Children's Research Institute, Melbourne, Victoria, Australia

Publication date: 01 June 2010

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more